Switch to:
Also traded in: Germany, Italy, Mexico, Switzerland, UK, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.12
OTCPK:FMCQF's Cash-to-Debt is ranked lower than
65% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. OTCPK:FMCQF: 0.12 )
Ranked among companies with meaningful Cash-to-Debt only.
OTCPK:FMCQF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.06 Max: N/A
Current: 0.12
Equity-to-Asset 0.40
OTCPK:FMCQF's Equity-to-Asset is ranked lower than
60% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. OTCPK:FMCQF: 0.40 )
Ranked among companies with meaningful Equity-to-Asset only.
OTCPK:FMCQF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.35  Med: 0.4 Max: 0.5
Current: 0.4
0.35
0.5
Interest Coverage 5.85
OTCPK:FMCQF's Interest Coverage is ranked lower than
57% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 7.25 vs. OTCPK:FMCQF: 5.85 )
Ranked among companies with meaningful Interest Coverage only.
OTCPK:FMCQF' s Interest Coverage Range Over the Past 10 Years
Min: 3.95  Med: 4.88 Max: 6.3
Current: 5.85
3.95
6.3
Piotroski F-Score: 6
Altman Z-Score: 2.46
Beneish M-Score: -2.53
WACC vs ROIC
4.58%
9.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.76
OTCPK:FMCQF's Operating Margin % is ranked higher than
79% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. OTCPK:FMCQF: 14.76 )
Ranked among companies with meaningful Operating Margin % only.
OTCPK:FMCQF' s Operating Margin % Range Over the Past 10 Years
Min: 13.9  Med: 15.69 Max: 16.51
Current: 14.76
13.9
16.51
Net Margin % 6.96
OTCPK:FMCQF's Net Margin % is ranked higher than
67% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.00 vs. OTCPK:FMCQF: 6.96 )
Ranked among companies with meaningful Net Margin % only.
OTCPK:FMCQF' s Net Margin % Range Over the Past 10 Years
Min: 6.15  Med: 7.65 Max: 8.6
Current: 6.96
6.15
8.6
ROE % 12.04
OTCPK:FMCQF's ROE % is ranked higher than
61% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. OTCPK:FMCQF: 12.04 )
Ranked among companies with meaningful ROE % only.
OTCPK:FMCQF' s ROE % Range Over the Past 10 Years
Min: 11.29  Med: 13.36 Max: 14.68
Current: 12.04
11.29
14.68
ROA % 4.73
OTCPK:FMCQF's ROA % is ranked higher than
57% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. OTCPK:FMCQF: 4.73 )
Ranked among companies with meaningful ROA % only.
OTCPK:FMCQF' s ROA % Range Over the Past 10 Years
Min: 4.31  Med: 5.3 Max: 6.22
Current: 4.73
4.31
6.22
ROC (Joel Greenblatt) % 41.03
OTCPK:FMCQF's ROC (Joel Greenblatt) % is ranked higher than
75% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. OTCPK:FMCQF: 41.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
OTCPK:FMCQF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 38.32  Med: 43.89 Max: 50.61
Current: 41.03
38.32
50.61
3-Year Revenue Growth Rate 16.30
OTCPK:FMCQF's 3-Year Revenue Growth Rate is ranked higher than
79% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. OTCPK:FMCQF: 16.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
OTCPK:FMCQF' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -17.8  Med: 9.6 Max: 18.5
Current: 16.3
-17.8
18.5
3-Year EBITDA Growth Rate 14.70
OTCPK:FMCQF's 3-Year EBITDA Growth Rate is ranked higher than
70% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. OTCPK:FMCQF: 14.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
OTCPK:FMCQF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 8.4 Max: 59.5
Current: 14.7
0
59.5
3-Year EPS without NRI Growth Rate 13.00
OTCPK:FMCQF's 3-Year EPS without NRI Growth Rate is ranked higher than
61% of the 132 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. OTCPK:FMCQF: 13.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
OTCPK:FMCQF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -25.8  Med: 12.95 Max: 62.7
Current: 13
-25.8
62.7
GuruFocus has detected 4 Warning Signs with Fresenius Medical Care AG & Co. KGaA $OTCPK:FMCQF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» OTCPK:FMCQF's 10-Y Financials

Financials (Next Earnings Date: 2017-05-22 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with OTCPK:FMCQF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Fresenius Medical Care AG & Co. KGaA

SymbolPriceYieldDescription
FME3.Germany54.200.96

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621492    SIC: 8092
Compare:NYSE:HCA, NYSE:DVA, NYSE:UHS, OTCPK:RMSYF, OTCPK:BDULF, NYSE:EVHC, NAS:WOOF, OTCPK:FSNUY, NYSE:MD, OTCPK:SKHCF, OTCPK:CAKFY, NYSE:HLS, NAS:ACHC, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, NAS:SCAI, NYSE:AMN, NYSE:THC, OTCPK:RAFLF » details
Traded in other countries:FMEN.Germany, FME.Italy, FMEN.Mexico, FME.Switzerland, 0H9X.UK, FMS.USA,
Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company, which is operating in both the field of dialysis products and dialysis services.

Based in Germany, Fresenius Medical Care is the largest global dialysis provider, with over 300,000 patients in North America, Europe, Latin America, and Asia. Fresenius operates over 2,270 clinics in North America, 700 in Europe, 360 in Asia-Pacific, and 230 in Latin America. Fresenius also sells dialysis machines and disposables, which represent nearly 20% of the company's revenue.

Ratios

vs
industry
vs
history
PE Ratio 21.32
FMCQF's PE Ratio is ranked higher than
65% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. FMCQF: 21.32 )
Ranked among companies with meaningful PE Ratio only.
FMCQF' s PE Ratio Range Over the Past 10 Years
Min: 13.24  Med: 20.03 Max: 29.4
Current: 21.32
13.24
29.4
Forward PE Ratio 18.98
FMCQF's Forward PE Ratio is ranked higher than
59% of the 83 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. FMCQF: 18.98 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 21.32
FMCQF's PE Ratio without NRI is ranked higher than
65% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 27.32 vs. FMCQF: 21.32 )
Ranked among companies with meaningful PE Ratio without NRI only.
FMCQF' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.24  Med: 20.03 Max: 29.4
Current: 21.32
13.24
29.4
Price-to-Owner-Earnings 21.93
FMCQF's Price-to-Owner-Earnings is ranked higher than
62% of the 93 Companies
in the Global Medical Care industry.

( Industry Median: 27.69 vs. FMCQF: 21.93 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
FMCQF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.4  Med: 21.64 Max: 36.52
Current: 21.93
12.4
36.52
PB Ratio 2.36
FMCQF's PB Ratio is ranked lower than
51% of the 225 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. FMCQF: 2.36 )
Ranked among companies with meaningful PB Ratio only.
FMCQF' s PB Ratio Range Over the Past 10 Years
Min: 1.64  Med: 2.5 Max: 3.01
Current: 2.36
1.64
3.01
PS Ratio 1.49
FMCQF's PS Ratio is ranked higher than
50% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. FMCQF: 1.49 )
Ranked among companies with meaningful PS Ratio only.
FMCQF' s PS Ratio Range Over the Past 10 Years
Min: 1.02  Med: 1.5 Max: 1.89
Current: 1.49
1.02
1.89
Price-to-Free-Cash-Flow 23.68
FMCQF's Price-to-Free-Cash-Flow is ranked higher than
51% of the 114 Companies
in the Global Medical Care industry.

( Industry Median: 23.68 vs. FMCQF: 23.68 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
FMCQF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 14.05  Med: 24.17 Max: 53.67
Current: 23.68
14.05
53.67
Price-to-Operating-Cash-Flow 12.35
FMCQF's Price-to-Operating-Cash-Flow is ranked higher than
59% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 13.47 vs. FMCQF: 12.35 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
FMCQF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.4  Med: 12.6 Max: 19.32
Current: 12.35
9.4
19.32
EV-to-EBIT 13.09
FMCQF's EV-to-EBIT is ranked higher than
77% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. FMCQF: 13.09 )
Ranked among companies with meaningful EV-to-EBIT only.
FMCQF' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.3  Med: 12.6 Max: 16.8
Current: 13.09
7.3
16.8
EV-to-EBITDA 10.16
FMCQF's EV-to-EBITDA is ranked higher than
72% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 14.29 vs. FMCQF: 10.16 )
Ranked among companies with meaningful EV-to-EBITDA only.
FMCQF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.8  Med: 10 Max: 13
Current: 10.16
5.8
13
PEG Ratio 2.22
FMCQF's PEG Ratio is ranked higher than
63% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 3.12 vs. FMCQF: 2.22 )
Ranked among companies with meaningful PEG Ratio only.
FMCQF' s PEG Ratio Range Over the Past 10 Years
Min: 1.07  Med: 2.3 Max: 36.43
Current: 2.22
1.07
36.43
Shiller PE Ratio 28.74
FMCQF's Shiller PE Ratio is ranked higher than
51% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.74 vs. FMCQF: 28.74 )
Ranked among companies with meaningful Shiller PE Ratio only.
FMCQF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 20.67  Med: 28.4 Max: 44.54
Current: 28.74
20.67
44.54
Current Ratio 1.45
FMCQF's Current Ratio is ranked higher than
57% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. FMCQF: 1.45 )
Ranked among companies with meaningful Current Ratio only.
FMCQF' s Current Ratio Range Over the Past 10 Years
Min: 0.87  Med: 1.44 Max: 1.93
Current: 1.45
0.87
1.93
Quick Ratio 1.17
FMCQF's Quick Ratio is ranked higher than
51% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.16 vs. FMCQF: 1.17 )
Ranked among companies with meaningful Quick Ratio only.
FMCQF' s Quick Ratio Range Over the Past 10 Years
Min: 0.7  Med: 1.15 Max: 1.61
Current: 1.17
0.7
1.61
Days Inventory 41.78
FMCQF's Days Inventory is ranked lower than
73% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 18.84 vs. FMCQF: 41.78 )
Ranked among companies with meaningful Days Inventory only.
FMCQF' s Days Inventory Range Over the Past 10 Years
Min: 33.91  Med: 37.82 Max: 41.78
Current: 41.78
33.91
41.78
Days Sales Outstanding 75.04
FMCQF's Days Sales Outstanding is ranked lower than
84% of the 174 Companies
in the Global Medical Care industry.

( Industry Median: 44.22 vs. FMCQF: 75.04 )
Ranked among companies with meaningful Days Sales Outstanding only.
FMCQF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.64  Med: 76 Max: 83.04
Current: 75.04
71.64
83.04
Days Payable 19.08
FMCQF's Days Payable is ranked lower than
76% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 39.67 vs. FMCQF: 19.08 )
Ranked among companies with meaningful Days Payable only.
FMCQF' s Days Payable Range Over the Past 10 Years
Min: 17.84  Med: 19.24 Max: 28.3
Current: 19.08
17.84
28.3

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.08
FMCQF's Dividend Yield % is ranked lower than
67% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 1.60 vs. FMCQF: 1.08 )
Ranked among companies with meaningful Dividend Yield % only.
FMCQF' s Dividend Yield % Range Over the Past 10 Years
Min: 0.93  Med: 1.32 Max: 2.07
Current: 1.08
0.93
2.07
Dividend Payout Ratio 0.22
FMCQF's Dividend Payout Ratio is ranked higher than
74% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 0.39 vs. FMCQF: 0.22 )
Ranked among companies with meaningful Dividend Payout Ratio only.
FMCQF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.22  Med: 0.27 Max: 0.31
Current: 0.22
0.22
0.31
3-Year Dividend Growth Rate 5.80
FMCQF's 3-Year Dividend Growth Rate is ranked lower than
69% of the 77 Companies
in the Global Medical Care industry.

( Industry Median: 10.10 vs. FMCQF: 5.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
FMCQF' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 8
Current: 5.8
0
8
Forward Dividend Yield % 1.08
FMCQF's Forward Dividend Yield % is ranked lower than
68% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. FMCQF: 1.08 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.37
FMCQF's 5-Year Yield-on-Cost % is ranked lower than
72% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 2.12 vs. FMCQF: 1.37 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
FMCQF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.18  Med: 1.67 Max: 2.62
Current: 1.37
1.18
2.62
3-Year Average Share Buyback Ratio -0.50
FMCQF's 3-Year Average Share Buyback Ratio is ranked higher than
75% of the 126 Companies
in the Global Medical Care industry.

( Industry Median: -2.40 vs. FMCQF: -0.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
FMCQF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -11.8  Med: -0.5 Max: 8
Current: -0.5
-11.8
8

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.15
FMCQF's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
75% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. FMCQF: 1.15 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
FMCQF' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.92  Med: 1.26 Max: 1.72
Current: 1.15
0.92
1.72
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.55
FMCQF's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
66% of the 32 Companies
in the Global Medical Care industry.

( Industry Median: 1.77 vs. FMCQF: 1.55 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 0.99
FMCQF's Price-to-Median-PS-Value is ranked higher than
59% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. FMCQF: 0.99 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
FMCQF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35  Med: 0.99 Max: 1.35
Current: 0.99
0.35
1.35
Price-to-Peter-Lynch-Fair-Value 2.58
FMCQF's Price-to-Peter-Lynch-Fair-Value is ranked lower than
62% of the 52 Companies
in the Global Medical Care industry.

( Industry Median: 1.75 vs. FMCQF: 2.58 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
FMCQF' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.18  Med: 2.07 Max: 3.58
Current: 2.58
1.18
3.58
Earnings Yield (Greenblatt) % 7.64
FMCQF's Earnings Yield (Greenblatt) % is ranked higher than
81% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.94 vs. FMCQF: 7.64 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
FMCQF' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.9  Med: 7.9 Max: 13.7
Current: 7.64
5.9
13.7
Forward Rate of Return (Yacktman) % 12.13
FMCQF's Forward Rate of Return (Yacktman) % is ranked higher than
58% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 10.02 vs. FMCQF: 12.13 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
FMCQF' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -5  Med: 11.2 Max: 16.3
Current: 12.13
-5
16.3

More Statistics

Revenue (TTM) (Mil) $17,911
EPS (TTM) $ 4.07
Beta0.63
Short Percentage of Float0.00%
52-Week Range $76.98 - 93.23
Shares Outstanding (Mil)306.22

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 19,211 20,664 22,038
EPS ($) 6.26 7.67 53.69
EPS without NRI ($) 6.26 7.67 53.69
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.36%
Dividends per Share ($) 1.00 1.06 1.11
» More Articles for OTCPK:FMCQF

Headlines

Articles On GuruFocus.com
Another Attempt to Trumpet a Mistake Dec 19 2016 
Baxter Well Positioned in Fast-Growing Market for Kidney Dialysis Equipment Jul 01 2016 
Weekly 52-Week Highs Highlight: FMS, MTB, LO, LEN Apr 05 2015 
Weekly 3-Year Low Highlights: FMS, SNOW, KMDA, LAYN Jun 16 2014 
Weekly 52-Week Highs Highlight: MMP, AZO, BEAM, FMS Jan 26 2014 
Better Know a Company: Fresenius Medical Care (FMS) Apr 23 2013 
Warren Buffett Becomes Largest Owner of DaVita Mar 04 2013 
Warren Buffett’s Holding of DaVita Grows as Company Expands Jan 17 2013 
Buffett’s Berkshire Hathaway Buys Even More DaVita Shares Nov 29 2012 
Edward Owens Buys Walgreen Co., UCBH Holdings Inc., OSI Pharmaceuticals Inc., Sells Ventana Medical Aug 02 2007 

More From Other Websites
Fresenius (FMS) to Jointly Develop Acumen with Epic Systems Mar 20 2017
Fresenius Medical Care AG & Co. KGaA :FMCQF-US: Earnings Analysis: 2016 By the Numbers : February... Feb 28 2017
Fresenius Medical Care AG & Co. KGaA :FMCQF-US: Earnings Analysis: Q4, 2016 By the Numbers :... Feb 27 2017
Fresenius Medical (FMS) Tops Earnings in Q4, View Upbeat Feb 23 2017
Fresenius Medical Care misses 4Q revenue forecasts Feb 22 2017
Fresenius Medical Care misses 4Q revenue forecasts Feb 22 2017
Fresenius Medical Care AG & Co. KGaA breached its 50 day moving average in a Bullish Manner :... Feb 17 2017
Dialysis provider FMC settles with U.S. veterans department Jan 31 2017
U.S. court issues injunction on assistance for dialysis patients Jan 26 2017
Fresenius Medical Care AG & Co. KGaA breached its 50 day moving average in a Bullish Manner :... Jan 23 2017
CTSO: Poised For Strong 2017. Fresenius Deal A Win-Win-Win Jan 16 2017
Fresenius Medical Care AG & Co. KGaA – Value Analysis (US OTC:FMCQF) : January 11, 2017 Jan 11 2017
Fresenius Medical Care AG & Co. KGaA breached its 50 day moving average in a Bearish Manner :... Jan 10 2017
Fresenius Medical Care Shares Dive After U.S. Subpoena Linked to American Kidney Fund Jan 09 2017
Dialysis Providers Fall After Disclosing Patient-Care Subpoenas Jan 09 2017
Fresenius Medical files suit over US rule change on renal disease care Jan 07 2017
How Kellogg Company (K) Stacks Up Against Its Peers Dec 10 2016
Hedge Funds Are Selling Sempra Energy (SRE) Dec 08 2016
Is Humana Inc (HUM) A Good Stock To Buy Right Now? Dec 01 2016
Leading Investors Aren’t Sure What to Make of Dollar General Corp. (DG) Nov 24 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)